First ever successful demonstration of superiority in an FDA-aligned wet AMD trial comparing a novel investigative agent to an approved anti-VEGF ...

AXPAXLI (TM) (also known as OTX-TKI) is an investigational, bioresorbable, intravitreal hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase inhibitor with anti-angiogenic ...

New Delhi [India], January 28: In 2025, as global trade faced pressure from shifting tariff structures, supply-chain disruptions, and geopolitical uncertainty, many Indian startups chose to delay ...

Scott Gaffner, from Greenville, Illinois, serves as Secretary of the US Soybean Export Council (USSEC) and is an At-Large ...

You’ve probably walked around the aisles of a supermarket or store just to compare the different items on offer. And I’m sure ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular”), an integrated biopharmaceutical company committed to redefining the retina ...

Many strategies fail not for lack of vision, but because employees don’t understand or aren’t sold on enacting them. A new ...

Without this history, students may see Black thinkers as footnotes rather than world-historical contributors. As we rise to confront Trump’s fascism, Truthout appeals for your support. Any ...

Secondary infections caused by bacteria or viruses during hospital care remain a long-standing global challenge, despite ...

Rising demand for high-performance lubricants across automotive, industrial machinery, marine, and energy sectors is driving sustained growth in the ...

Climb Bio (NASDAQ:CLYM) outlined a slate of near-term clinical milestones and its broader autoimmune disease strategy during ...

The Oct. 7 attack was a massacre. But Israeli authorities would prefer you not call it that. The Prime Minister’s Office ...